Clinical trials

  • INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2); INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN; A/VICTORIA/4897/2022 (H1N1)PDM09-LIKE STRAIN for Influenza
  • CICLOPIROX for Onychomycosis
  • AUTologous adipose tissue-derived stromal vascular fraction cells for Crohn's disease | Fistulising Crohn's disease
  • PERTECHNETATE (99MTC) SODIUM for Ovarian cancer|Early-stage ovarian cancer
  • RESPIRATORY SYNCYTIAL VIRUS, GLYCOPROTEIN F, RECOMBINANT, STABILISED IN THE PRE-FUSION CONFORMATION, ADJUVANTED WITH AS01E for Respiratory syncytial virus infection
  • Daratumumab for Myalgic encephalomyelitis | Chronic fatigue syndrome
  • SYNTHETIC DOUBLE-STRANDED SIRNA OLIGONUCLEOTIDE DIRECTED AGAINST APOLIPOPROTEIN C-III MRNA AND COVALENTLY LINKED TO A LIGAND CONTAINING THREE N-ACETYLGALACTOSAMINE RESIDUES for Hypertriglyceridemia
  • Cytolityc T Lymphocytes for Cytomegalovirus infection (post-allogeneic hematopoietic stem cell transplantation)
  • gadobutrol for Cerebrospinal fluid disorders|Cognitive impairment|Central nervous system neoplasm|Hydrocephalus|Fatigue
  • Leuprorelin acetate for Early breast cancer
  • Melatonin for Primary insomnia
  • ZANIDATAMAB for Gastroesophageal adenocarcinoma|Metastatic gastroesophageal adenocarcinoma